异噻唑啉酮衍生物与变应性接触性皮炎:综述与更新
本文综述了不同异噻唑啉酮类化合物接触过敏的流行病学、异噻唑啉酮诱发变应性接触性皮炎的临床表现、最相关致敏来源及异噻唑啉酮衍生物间潜在交叉反应,并提供了近期立法措施的更新。文章指出,尽管甲基氯异噻唑啉酮/甲基异噻唑啉酮(MCI/MI)和MI所致变应性接触性皮炎患病率下降,但职业暴露和非化妆品来源异噻唑啉酮所致病例呈上升趋势,且已有对更新、较少已知异噻唑啉酮的致敏报道。
要点
- MCI/MI和MI所致变应性接触性皮炎患病率下降,但职业和非化妆品来源病例上升。
- 已有对更新、较少已知异噻唑啉酮致敏的报道。
- 综述涵盖异噻唑啉酮接触过敏的流行病学、临床表现、致敏来源和交叉反应。
核心结论
- 尽管MCI/MI和MI所致变应性接触性皮炎患病率下降,但职业暴露和非化妆品异噻唑啉酮来源所致病例呈上升趋势,且已有对更新、较少已知异噻唑啉酮的致敏报道。
研究设计与样本
- 综述与更新,检索范围未在原文中明确报告。
主要发现
- MCI/MI和MI所致变应性接触性皮炎患病率下降,但职业暴露和非化妆品异噻唑啉酮来源所致病例上升。
- 已有对更新、较少已知异噻唑啉酮致敏的报道。
关键数值与推荐
- 欧盟委员会消费者安全科学委员会禁止MCI/MI和MI在驻留类产品中使用,同时限制其在淋洗类化妆品中的使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allergic contact dermatitis (ACD) from isothiazolinones has frequently been described in the literature. Following an epidemic of sensitization to methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) in the 1980s, and more recently to MI, the Scientific Committee on Consumer Safety of the European Commission banned their use in leave-on products, while restricting that in rinse-off cosmetics. Despite a decreasing prevalence of ACD from MCI/MI and MI, cases caused by occupational exposure and non-cosmetic isothiazolinone sources are on the rise. Moreover, sensitization to newer and lesser known isothiazolinones has been reported. This paper reviews the epidemiology of contact allergy to different isothiazolinones, clinical presentation of isothiazolinone-induced ACD, most relevant sensitization sources and potential cross-reactions between isothiazolinone derivatives. It also provides an update on recent legislative measures.
引用
- Herman A, Aerts O, de Montjoye L, et al. Isothiazolinone derivatives and allergic contact dermatitis: a review and update. J Eur Acad Dermatol Venereol. 2019. PMID: 30284765. doi:10.1111/jdv.15267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。